Polarityte Inc (NASDAQ:PTE) – Equities researchers at Cantor Fitzgerald boosted their FY2019 earnings estimates for shares of Polarityte in a report issued on Tuesday, October 15th. Cantor Fitzgerald analyst E. Piros now forecasts that the company will earn ($3.73) per share for the year, up from their prior forecast of ($3.76). Cantor Fitzgerald has a “Buy” rating and a $50.00 price objective on the stock. Cantor Fitzgerald also issued estimates for Polarityte’s FY2020 earnings at ($2.82) EPS.

Other analysts also recently issued reports about the company. Oppenheimer set a $14.00 price objective on Polarityte and gave the stock a “buy” rating in a research report on Wednesday, August 21st. Northland Securities set a $20.00 price objective on Polarityte and gave the stock a “buy” rating in a research report on Friday, October 11th. HC Wainwright assumed coverage on Polarityte in a research report on Monday, July 8th. They set a “buy” rating and a $8.00 price objective for the company. Zacks Investment Research downgraded Polarityte from a “buy” rating to a “hold” rating in a research report on Friday. Finally, ValuEngine upgraded Polarityte from a “hold” rating to a “buy” rating in a research report on Tuesday, July 2nd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and seven have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $19.38.

Shares of PTE stock opened at $2.82 on Friday. The company has a quick ratio of 6.68, a current ratio of 6.72 and a debt-to-equity ratio of 0.06. Polarityte has a twelve month low of $2.71 and a twelve month high of $18.17. The company has a market cap of $79.28 million, a P/E ratio of -0.58 and a beta of 1.45. The business has a fifty day simple moving average of $3.64 and a 200 day simple moving average of $5.81.

Polarityte (NASDAQ:PTE) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.92) earnings per share for the quarter, topping the consensus estimate of ($1.05) by $0.13. The business had revenue of $1.32 million for the quarter, compared to the consensus estimate of $1.57 million. During the same quarter in the prior year, the company earned ($0.74) earnings per share. Polarityte’s quarterly revenue was up 312.5% compared to the same quarter last year.

A number of institutional investors have recently bought and sold shares of the business. GSA Capital Partners LLP increased its stake in shares of Polarityte by 415.8% in the second quarter. GSA Capital Partners LLP now owns 69,927 shares of the company’s stock valued at $399,000 after buying an additional 56,370 shares during the period. Comprehensive Portfolio Management LLC increased its stake in shares of Polarityte by 29.9% in the second quarter. Comprehensive Portfolio Management LLC now owns 28,200 shares of the company’s stock valued at $161,000 after buying an additional 6,498 shares during the period. Bernardo Wealth Planning LLC acquired a new stake in shares of Polarityte in the second quarter valued at about $68,000. Cheyne Capital Management UK LLP increased its stake in shares of Polarityte by 10.5% in the second quarter. Cheyne Capital Management UK LLP now owns 109,098 shares of the company’s stock valued at $622,000 after buying an additional 10,400 shares during the period. Finally, Marshall Wace North America L.P. increased its stake in shares of Polarityte by 178.6% in the second quarter. Marshall Wace North America L.P. now owns 19,020 shares of the company’s stock valued at $109,000 after buying an additional 12,194 shares during the period. Hedge funds and other institutional investors own 41.51% of the company’s stock.

Polarityte Company Profile

PolarityTE, Inc, a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services.

Featured Story: What is the CBOE Russell 2000® Volatility Index?

Earnings History and Estimates for Polarityte (NASDAQ:PTE)

Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.